Browse the evidence

Expanding first-level genetic screening for obesity to include POMC and MC3R genes is necessary to maximize diagnostic yield and identify patients with intermediate susceptibility phenotypes who are missed by standard panels.

If you have obesity and standard genetic tests came back negative, ask your doctor about expanded testing for POMC and MC3R genes. This can reveal if you have a specific biological susceptibility that might affect how your body handles energy, potentially guiding more personalized treatment strategies.

GLP-1 and dual GIP/GLP-1 receptor agonists exert neuropsychiatric effects by modulating central neurotransmitter systems (dopamine, serotonin, GABA, glutamate) and promoting neuroplasticity, potentially treating addiction, depression, and cognitive decline.

GLP-1 and dual agonists (like semaglutide and tirzepatide) do more than just suppress appetite; they interact with brain receptors that regulate mood, reward, and memory. While they are primarily prescribed for diabetes and weight loss, research suggests they may also help with conditions like addiction, depression, and cognitive decline by balancing neurotransmitters like dopamine and serotonin. However, patients should be aware that while serious psychiatric side effects are rare and not consistently linked to the drugs, isolated reports of mood changes exist, so monitoring mental health is recommended.

GLP-1RAs are associated with rare but serious adverse events including acute pancreatitis, gallbladder disease, and potential worsening of diabetic retinopathy, though causal relationships for some (like thyroid cancer) are not confirmed in humans.

Be aware of rare but serious side effects like pancreatitis, gallbladder disease, and worsening of diabetic retinopathy (especially if you have pre-existing eye disease). While the risk of thyroid cancer is a concern in animal studies, no human cases have been confirmed. Report any severe abdominal pain or vision changes to your doctor.

Topical cosmetic peptides (e.g., GHK-Cu, Matrixyl, Argirelin) reduce wrinkles and improve skin firmness with excellent safety profiles, though effects are modest and require consistent long-term use.

Topical peptides like GHK-Cu, Matrixyl, and Argirelin can help reduce wrinkles and improve skin firmness when applied consistently over 8-12 weeks. They are generally safe and well-tolerated, but the effects are modest compared to injectable treatments. Regular use is necessary to maintain benefits.

High-dose tirzepatide (10–15 mg/week) is associated with a statistically significant increase in the risk of acute kidney injury (AKI) compared to control treatments.

If you are prescribed high-dose tirzepatide (10-15 mg/week), be aware of a small but statistically significant increased risk of acute kidney injury. Stay well-hydrated, especially if you experience gastrointestinal side effects like nausea or diarrhea, as volume depletion can trigger AKI. Monitor your kidney function as recommended by your doctor, and report any sudden changes in urination or swelling immediately.

Resistance training frequency (2x vs 4x per week) does not significantly alter patellar tendon morphological adaptations (Cross-Sectional Area or Length) when volume is equated.

Do not expect your tendons to get thicker (hypertrophy) from 8-12 weeks of resistance training, regardless of whether you train 2 or 4 times a week. Focus on strength gains, which can occur without visible morphological changes in this timeframe.

In routine clinical practice, sporadic individual dietary consultations do not significantly improve adherence to the Mediterranean diet in patients with type 2 diabetes.

If you have type 2 diabetes, simply attending a dietitian appointment once or twice a year is unlikely to change your diet significantly. To get results, you need intensive, ongoing support that provides concrete tools and food, not just sporadic advice. If you feel you already know how to eat well, focus on maintaining that consistency rather than seeking more general advice.

In Korean adults, adherence to a low-carbohydrate diet (LCD) is associated with higher odds of metabolic syndrome, primarily because LCDs in this population often substitute refined carbohydrates with processed meats and animal fats rather than healthy unsaturated fats.

If you are Korean or have an East Asian metabolic profile, simply reducing carbohydrates may not lower your metabolic syndrome risk and could potentially increase it if you replace rice with processed meats or unhealthy fats. Focus on the quality of your diet—choosing whole grains, unsaturated fats, and lean proteins—rather than just cutting carbs.

There is no significant difference between various macronutrient dietary groups (VLCLP, MCLP, MCHP, etc.) in their ability to lower blood glucose, blood pressure, or total cholesterol compared to a moderate fat-low protein (MFLP) control diet.

Do not expect that switching to a specific macronutrient ratio (like Keto or Low Fat) will significantly lower your blood pressure, blood glucose, or total cholesterol compared to a standard moderate-fat diet. The evidence for these specific outcomes is weak and shows no clear winner among the diets studied.

While dietary fiber consistently modulates gut microbiota composition and fermentation markers (SCFAs), evidence for direct physiological health benefits (e.g., changes in blood lipids, glucose, insulin, or satiety) from fiber-induced microbiota modulation is limited and inconsistent in current literature.

Don't expect immediate changes in blood sugar or cholesterol from fiber alone. The primary benefit is supporting gut bacteria. Focus on long-term consistency rather than quick fixes.

Obesity is associated with disrupted functional brain network organization, specifically weakened connectivity in the executive control network (ECN) and enhanced connectivity in the salience (SN) and default mode networks (DMN), which correlates with impairments in self-regulation and reward valuation.

Recognize that obesity involves changes in brain networks that affect self-control and reward processing. This is not a moral failing but a biological factor that can be targeted. Interventions that specifically train self-regulation and attentional control may be more effective than standard advice alone, as these neural patterns are modifiable.

Stronger baseline connectivity between the dorsolateral prefrontal cortex (dlPFC) and ventromedial prefrontal cortex (vmPFC) predicts greater weight loss following a dietary intervention, suggesting that this neural pattern facilitates dietary impulse control.

If you have strong self-regulation capabilities (reflected in dlPFC-vmPFC connectivity), you may respond better to standard dietary interventions. For those with weaker connectivity, targeted training in self-regulation and impulse control might be necessary to achieve similar weight loss results.

Consumption of meat and meat-products, particularly those high in heme iron and polyunsaturated fatty acids, induces oxidative stress through the generation of reactive aldehydes (MDA, 4-HNE) and advanced glycation end-products (AGEs) during digestion and metabolism.

To minimize oxidative stress from meat, prioritize meats with lower heme iron and PUFA content where possible, and be aware that processing, cooking, and storage methods significantly increase the formation of oxidation compounds like MDA and 4-HNE. Pairing meat with antioxidant-rich plant foods may help mitigate some oxidative damage, though the paper emphasizes the need for personalized nutrition based on genetic susceptibility.

Pinitol-enriched beverage intake increases serum levels of Complement C4A and IGF1BP-ALS in individuals with Impaired Glucose Tolerance (IGT), which correlates with increased GLUT2 expression in the jejunum.

This node describes the biological mechanism rather than a direct user action. It suggests that the glucose-lowering effect of pinitol is mediated by specific protein changes (C4A, IGF1BP-ALS) and gut glucose transporter expression (GLUT2), particularly in those with pre-diabetic conditions.

The protective effect of psychological resilience on physical disability and grip strength is attenuated in individuals with frequent hospitalizations (2+ per year).

If you have been hospitalized frequently, psychological resilience might not be enough to maintain your physical strength on its own. This doesn't mean resilience is worthless, but it suggests that for those with high medical burden, resilience must be supported by robust medical care and physical therapy. Focus on preventing hospitalizations to allow resilience to do its protective work.

Genetic predisposition to obesity, measured by a cumulative score of five specific SNPs (FTO, TMEM18, MC4R, SEC16B, BDNF), does not significantly predict weight loss outcomes in adults undergoing behavioral weight loss interventions.

Do not rely on genetic testing to predict your weight loss success. This study of nearly 600 people found that having 'obesity genes' did not stop them from losing weight, nor did it guarantee it. Behavioral interventions work regardless of these specific genetic markers. Focus on the intervention itself (diet, activity, behavior) rather than your genotype.

Chronic low-grade inflammation and oxidative stress in MASLD drive atrial structural and electrical remodeling, creating an arrhythmogenic substrate for AF.

Treating MASLD involves more than just liver health; it requires addressing systemic inflammation and oxidative stress to protect the heart from structural remodeling that leads to AF.

High consumption of carbohydrates, specifically from cereals and starchy roots, is consistently associated with increased risk of cardiovascular diseases (CVDs), including raised blood pressure, CVD mortality, and raised blood glucose, across global populations.

Focus on reducing the proportion of energy derived from high-glycemic carbohydrates, particularly cereals (like wheat) and starchy roots, as this is consistently linked to higher cardiovascular risk globally. This does not necessarily mean eliminating these foods, but rather managing their quantity and type relative to other macronutrients.

Central administration of leptin or FGF1 can reverse basal hyperglycemia in diabetic animal models through insulin-independent mechanisms, without improving glucose tolerance.

This finding in animals suggests that targeting the brain with specific hormones (like leptin or FGF1) can lower blood sugar without needing insulin. This supports the development of brain-targeted therapies for diabetes that work independently of pancreatic insulin secretion.

The bitter taste of polyphenol-rich oils (e.g., olive, flaxseed) significantly limits dietary acceptance and ingestion, thereby reducing the cardiovascular health benefits of these fatty acids.

If you dislike the bitter taste of healthy oils like olive or flaxseed, don't skip them. Use processing tricks like heating the oil (for cooking), storing it cold, or mixing it with flavored foods (like milled flax in muffins) to mask the bitterness. This makes it easier to actually eat them and get the heart benefits.

Higher expression of Cardiotrophin-1 (CT-1) in subcutaneous femoral adipose tissue (scFEM) is associated with lower visceral adiposity, lower intrahepatic lipid, and greater insulin sensitivity in women with obesity.

For women with obesity, higher levels of the adipokine CT-1 in the femoral (thigh/buttock) fat depot are linked to better metabolic health, including lower liver fat and better insulin sensitivity. This suggests that lower-body fat distribution may be metabolically protective compared to abdominal fat, potentially mediated by CT-1 secretion.

Higher baseline expression of Cardiotrophin-1 (CT-1) in subcutaneous abdominal adipose tissue (scABD) protects men from the decline in insulin sensitivity typically caused by sustained overfeeding.

In lean men, higher baseline levels of the adipokine CT-1 in abdominal fat are associated with better preservation of insulin sensitivity during periods of overeating. This suggests that individual differences in adipose tissue biology may protect against diet-induced metabolic decline.

Short-term creatine supplementation (20g/day for 7 days) does not improve lower-limb muscle endurance or total work volume following an acute bout of aerobic exercise in trained young men.

If you are a trained male eating a high-protein diet, taking 20g of creatine daily for a week will not help you maintain leg strength after a hard cardio session. You likely do not need creatine for this specific purpose if your diet is already adequate.

An acute increase in fibroblast growth factor 21 (FGF21) in response to low-protein overfeeding serves as a biomarker identifying individuals with a 'thrifty' metabolism who are susceptible to weight gain.

If you struggle with weight gain despite similar efforts to others, your body's hormonal response (specifically FGF21) to certain dietary stresses might be the cause. This isn't about willpower; it's a physiological 'thrifty' phenotype. Future testing may allow you to identify this susceptibility early, shifting focus from generic advice to targeted prevention.